Avita Medical Inc (RCEL)

EBITDA Growth

31.43%

Quarterly · Period ending:

RCEL logo

RCEL EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported31.43%
RCEL Quarterly EBITDA YoY % (-33.59% → 31.43%)
High-resolution chart · PNG

RCEL ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Avita Medical Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
31.4349%
29.1477%
1.5715%
22.2054%
41.2557%
29.1288%
-71.7096%
-70.7986%
-35.1439%
-88.5869%
-10.6104%
-56.7463%
-67.07%
2.6355%
36.795%
5.5392%
-35.1005%
-59.8075%
-50.3407%
42.4042%
64.9124%
76.5174%
62.9717%
-25.7684%
-26.4202%
-145.084%
-107.6798%
-1.9482%
-67.5172%
-90.5087%
-94.4733%
-116.7673%
-52.5711%
-32.9324%
-58.6282%
-56.487%
-31.6064%
-30.58%
11.3325%
11.5202%
-21.5443%
-22.7555%
-47.0379%
-39.9309%
-48.4217%
-49.7847%
-16.9767%
-10.7965%
25.9679%
27.2921%
23.5468%
11.1498%
-29.7659%
-33.5885%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.